Merck Settles Lawsuits
Merck and Company has agreed to settle two lawsuits filed by investors who say the drugmaker delayed releasing bad news on cholesterol drugs. The suits claim the company withheld information to prevent a drop in sales for Zetia and Vytorin. Merck has agreed to settle the class action suit brought by several pension funds for $688,000,000.